While acute inflammation is part of the defenseresponse that may participate in the remission of preclinical cancers, chronicinflammation can promote tumor development with infiltrating innate immunecells providing proinflammatory and proangiogenic factors including cytokines,chemokines, VEGF, and prostanoids [70–72]. The gene discussed is VEGFA; the disease is cancer.